GLP ‐2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide
Physiological Reports · 2025
DOI: 10.14814/phy2.70699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Reports, 2025. Verfasst von Katrine D Galsgaard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 2, Nitric Oxide, Mesenteric Artery, Superior, Gastric Inhibitory Polypeptide. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden (NNF).
Abstract (Originalsprache)
Following a meal, splanchnic blood flow increases. This is important for nutrient absorption and is regulated by the enteric nervous system and gastrointestinal (GI) hormones. Specifically, postprandial release of two GI hormones—glucagon‐like peptide‐2 (GLP‐2) and glucose‐dependent insulinotropic polypeptide (GIP) has been implicated in the regulation of splanchnic blood flow. We investigated the acute effects of GLP‐2 and GIP alone or in combination on superior mesenteric artery blood flow in anesthetized rats using a transit‐time flow probe and potential mediators of the GLP‐2 and GIP effects using a nitric oxide (NO) synthase inhibitor and a vasoactive intestinal peptide (VIP) receptor antagonist. We also investigated the effects of a newly developed (human) GIP/GLP‐2 receptor co‐agonist and the effects of the GLP‐2 receptor antagonist, GLP‐2(3–33). Both GLP‐2, GIP, and the co‐agonist acutely increased superior mesenteric artery blood flow in anesthetized rats. The increase in blood flow was independent of the NO synthase inhibitor and VIP receptor antagonism. A synergistic effect of GLP‐2 and GIP combined, or the GIP/GLP‐2 receptor co‐agonist, could not be demonstrated. GLP‐2(3–33) effectively antagonized the GLP‐2‐induced increase in superior mesenteric artery blood flow. Our results establish GLP‐2 and GIP as potent stimulators of superior mesenteric artery blood flow in anesthetized rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Katrine D Galsgaard, Jens J Holst, Charlotte M Sørensen
Förderung
- Novo Nordisk Fonden (NNF)
Zitieren
APA
Galsgaard, K. D., Hartmann, B., Rosenkilde, M. M., Holst, J. J., Gasbjerg, L. S., & Sørensen, C. M. (2025). GLP ‐2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide. Physiological Reports. https://doi.org/10.14814/phy2.70699
Vancouver
Galsgaard KD, Hartmann B, Rosenkilde MM, Holst JJ, Gasbjerg LS, Sørensen CM. GLP ‐2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide. Physiological Reports. 2025. doi:10.14814/phy2.70699
BibTeX
@article{Galsgaard2025,
author = {Galsgaard, Katrine D and Hartmann, Bolette and Rosenkilde, Mette M and Holst, Jens J and Gasbjerg, Lærke S and Sørensen, Charlotte M},
title = {GLP ‐2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide},
journal = {Physiological Reports},
year = {2025},
doi = {10.14814/phy2.70699}
}
EUVIMED